1. Carretero OA, Oparil S. Essential hypertension. Part I: definition and etiology. Circulation 2000; 101(4): 329-335.
2. Brown MJ. Science, medicine and the future: hypertension. BMJ 1997; 314(7089): 1258-1261.
3. Luft FC. Molecular genetics of human hypertension. J Hypertens 1998; 16(Pt 2): 1871-1878.
4. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams SC, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P. Molecular basis of hu-man hypertension. Role of angiotensionogen. Cell 1992; 71(1): 169-180.
5. Nakajima T, Jorde LB, Ishigami T, Umemura S, Emi M, Lalouel JM, Inoue I. Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet 2002; 70(1): 108-123.
6. Poncz M, Solowiejczyk D, Harpel B, Mory Y, Schwartz E, Surrey S. Construction of human gene libraries from small amounts of peripheral blood: analyses of b-like globin genes. Hemoglobin 1982; 6(1): 27-36.
7. Russ AP, Maerz W, Ruzcka V, Stein U, Gross W. Rapid detection of the hypertension associated Met235® Thr allele of the human angiotensinogen gene. Hum Mol Genet 1993; 2(5): 609-610.
8. Danziger RS. Hypertension in an anthropological and evolutionary paradigm. Hypertension 2001; 38(1): 19-22.
9. Kunz R. Association between angiotensinogen M235T variant and essential hypertension in Whites: a systemic review and a methodological appraisal. Hypertension 1997; 30(6): 1331-1337.
10. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM. Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994; 93(3): 1285-1287 .
11. Iwai N, Shimoike H, Ohmichi N, Kinoshita M. Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995; 25(Pt 2): 688-693.
12. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou JP, Luc G, Evans AE, Nicaud V, Cambien F. Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction. The ECTIM Study. J Hypertens 1995; 13(?):311-317.
13. Sethi AA, Nordestgaard BG, Agerholm-Larsen B, Frandsen E, Jensen G, Tybjarg-Hansen A. Angiotensinogen polymorphisms and elevated blood pressure in the general population. The Copenhagen City Heart Study. Hypertension 2001; 37(3):875-881.
14. Krizanova O. Molecular variants of the renin-angiotensin system components in the Slovak population. Physiol Res 1997; 46(5): 357-361.
15. Hudecova S. DNA analyses in the determination of a predisposition for hypertension. Bratisl Lek Listy. 1995; 96(6): 322-325.
16. Schunkert H, Hense HW, Gimenez-Roqueplo A-P, Stieber J, Keil U, Riegger GAJ, Jeunemaitre X. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population based-cochord. Hypertension 1997; 29(2): 628-633.
17. Procopsius L. Essential arterial hypertension and polymorphysm of angiotensinogen M235T gene. J Cell Mol Med 2000; 6(2): 245-250.
18. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330(23): 1629-1633.
19. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, Lawson M, De Freitas P, Fogarty P, Clark AJ. Linkage of the angiotensinogen gene locus to human essential hypertension in African Carribeans. J Clin Invest 1995; 96(2): 687-692.
20. Poch E. Molecular bases of salt sensitivity in human hypertension. Evaluation of RAS gene polymorphisms. Hypertension 2001; 38(5): 1204-1209.
21. Vasku A. Soucek M, Tschoplova S, Stejskalova A. An association of BMI with A(-6)G, M235T and T174M polymorphisms in angiotensinogen gene in essential hypertension. J Hum Hypertens 2002; 16(6): 427-430.
22. Bloem LJ, Manatunga AK, Tewskbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in black and white children. J Clin Invest 1995; 95(3): 948-953.
